A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.

Darragh LB, Knitz MM, Hu J, Clambey ET, Backus J, Dumit A, Samedi V, Bubak A, Greene C, Waxweiler T, Mehrotra S, Bhatia S, Gadwa J, Bickett T, Piper M, Fakhoury K, Liu A, Petit J, Bowles D, Thaker A, Atiyeh K, Goddard J, Hoyer R, Van Bokhoven A, Jordan K, Jimeno A, D'Alessandro A, Raben D, McDermott JD, Karam SD.

Open source

DOI: 10.1038/s43018-022-00450-6
Published: 2022-11-25
Container: Nat Cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43018-022-00450-6,
  title = {A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.},
  author = {Darragh LB and  Knitz MM and  Hu J and  Clambey ET and  Backus J and  Dumit A and  Samedi V and  Bubak A and  Greene C and  Waxweiler T and  Mehrotra S and  Bhatia S and  Gadwa J and  Bickett T and  Piper M and  Fakhoury K and  Liu A and  Petit J and  Bowles D and  Thaker A and  Atiyeh K and  Goddard J and  Hoyer R and  Van Bokhoven A and  Jordan K and  Jimeno A and  D'Alessandro A and  Raben D and  McDermott JD and  Karam SD.},
  year = {2022},
  journal = {Nat Cancer},
  doi = {10.1038/s43018-022-00450-6},
  url = {https://doi.org/10.1038/s43018-022-00450-6}
}

RIS

TY  - JOUR
TI  - A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
AU  - Darragh LB
AU  -  Knitz MM
AU  -  Hu J
AU  -  Clambey ET
AU  -  Backus J
AU  -  Dumit A
AU  -  Samedi V
AU  -  Bubak A
AU  -  Greene C
AU  -  Waxweiler T
AU  -  Mehrotra S
AU  -  Bhatia S
AU  -  Gadwa J
AU  -  Bickett T
AU  -  Piper M
AU  -  Fakhoury K
AU  -  Liu A
AU  -  Petit J
AU  -  Bowles D
AU  -  Thaker A
AU  -  Atiyeh K
AU  -  Goddard J
AU  -  Hoyer R
AU  -  Van Bokhoven A
AU  -  Jordan K
AU  -  Jimeno A
AU  -  D'Alessandro A
AU  -  Raben D
AU  -  McDermott JD
AU  -  Karam SD.
PY  - 2022
JO  - Nat Cancer
DO  - 10.1038/s43018-022-00450-6
UR  - https://doi.org/10.1038/s43018-022-00450-6
ER  -

APA

LB, D., MM, K., J, H., ET, C., J, B., A, D., V, S., A, B., C, G., T, W., S, M., S, B., J, G., T, B., M, P., K, F., A, L., J, P., D, B., A, T., K, A., J, G., R, H., A, V. B., K, J., A, J., A, D., D, R., JD, M., & SD., K. (2022). A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.. Nat Cancer. https://doi.org/10.1038/s43018-022-00450-6

Source records

europe-pmc · retrieved 2026-09-26T22:41:13.267Z